# Havencrest Capital Management

> Havencrest Capital Management is a Dallas-based private equity firm that invests exclusively in lower middle-market healthcare companies. Founded in 2018 by physician-investor Christopher W. Kersey, M.D., the firm buys majority stakes in founder-owned businesses - home care, clinical trials, behavioral health, hospice, and healthcare staffing - and helps them scale. It manages more than $600 million in assets and closed its second fund at $356 million in 2022.

- **Founded:** 2018
- **Headquarters:** Dallas, United States
- **Founders:** Christopher W. Kersey (Founding Managing Partner)
- **Team size:** ~28 employees
- **Products:** Control Buyouts & Majority Recapitalizations, Growth Equity Financing, Portfolio Resource Group, Havencrest Healthcare Partners I, Havencrest Healthcare Partners II
- **Notable:** Closed Fund II at a $356M hard cap in 2022, exceeding its $300M target, Reported Fund I performance of 65% net IRR, 3.2x net MOIC and 1.4x+ net DPI, Grew to $600M+ in assets under management within roughly four years of founding

## Products & services

- **Control Buyouts & Majority Recapitalizations** — Havencrest acquires majority stakes in founder-owned healthcare companies, providing liquidity to founders while keeping them involved in the business.
- **Growth Equity Financing** — Minority growth capital for healthcare companies partnering alongside like-minded co-investors.
- **Portfolio Resource Group** — An in-house operating team that supports portfolio companies on business development, sales and marketing, and operational scaling.
- **Havencrest Healthcare Partners I** — The firm's debut healthcare-focused private equity fund, reported to have generated strong net returns.
- **Havencrest Healthcare Partners II** — The firm's second fund, closed at a $356 million hard cap above its $300 million target.

## Achievements

- Closed Fund II at a $356M hard cap in 2022, exceeding its $300M target
- Reported Fund I performance of 65% net IRR, 3.2x net MOIC and 1.4x+ net DPI
- Grew to $600M+ in assets under management within roughly four years of founding
- Achieved a 110% re-up rate from existing limited partners into Fund II
- Built multiple healthcare platforms including Avid Health at Home, Tekton Research and Focus Staff

## Latest updates

- **2025-01** — Expanded the Avid Health at Home post-acute care platform with acquisitions including Home Care Angels and Private Duty Home Healthcare, and welcomed a new Executive Operating Partner.
- **2025-01** — Completed a majority recapitalization of OFFOR Health.
- **2023-01** — Made a majority investment in Tekton Research, a clinical trial site network, and acquired Focus Staff Services.

## Links

- Website: https://havencrest.com
- LinkedIn: http://www.linkedin.com/company/havencrest-capital-management

---

Profile page: https://yespress.io/havencrest-capital-management
Published by YesPress — https://yespress.io
Last updated: 2026-08-16